News

Cordex Pharma, a developer of cardiovascular medicines, has filed a formulation patent covering its lead product, ATPace. ATPace is a stable liquid formulation of adenosine triposphate (ATP) for

Anika Therapeutics, a developer and marketer of therapeutic products for tissue protection, healing and repair, has reported net income of $1.09m or $0.10 per diluted share for the

Bristol-Myers Squibb Company has signed a global collaboration agreement with Japan-based manufacturing company Nissan Chemical Industries, and Teijin Pharma for the development and commercialization of NTC-801, a selective

ThromboGenics, a biotechnology company, has completed patient enrollment for a Phase II trial of microplasmin intravitreal injection for the treatment of diabetic macular edema. According to the company,

Proteon Therapeutics, a biopharmaceutical company, has successfully completed a $38m series B equity financing, led by MPM Capital on behalf of the MPM Bio IV NVS Strategic Fund.

Financial Highlights Reported revenues up 27.8% to GBP85.3 million (2007: GBP66.7 million); constant currency revenue growth of 14.3% Point-of-care (PoC) Division revenues up 37.4% to GBP34.3 million (2007:

Schering-Plough has received both the European Commission and the FDA approvals for the intravenous formulation of temozolomide as an alternative to the already approved oral form of the

For the fourth quarter of 2008, Neoprobe had a net loss of $1.2 million or $0.02 per share compared to a net loss of $1.9 million or $0.03

Prior to joining Biolase, Mr Capallo spent 10 years as director of corporate accounting for Irvine-based Interpore International, a manufacturer and distributor of orthopedic products including spinal implants,